Pharmaceutical Manufacturers Ask Eastern District of Virginia to Allow Cost-Sharing Under the AKS
Pharmaceutical manufacturers are challenging the breadth of the Federal Anti-Kickback Statute in federal court, arguing that the government is harming the very vulnerable patients it aims to serve by prohibiting cost-sharing subsidies for life-saving oncology drugs.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every case digest, six days a week.
$750/year